Magnetar Financial’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,067
Closed -$210K 764
2024
Q4
$210K Buy
+3,067
New +$214K ﹤0.01% 546
2024
Q2
Sell
-580,508
Closed -$46.5M 517
2024
Q1
$46.5M Buy
580,508
+567,220
+4,269% +$50.6M 1.04% 30
2023
Q4
$1.46M Buy
+13,288
New +$1.37M 0.04% 226
2023
Q1
Sell
-229,166
Closed -$20.3M 626
2022
Q4
$20.3M Buy
229,166
+136,930
+148% +$11.4M 0.34% 71
2022
Q3
$7.39M Buy
92,236
+80,857
+711% +$7.63M 0.1% 232
2022
Q2
$1.09K Buy
+11,379
New +$1.37M 0.01% 937
2021
Q3
Sell
-1,518
Closed -$209 1342
2021
Q2
$209 Buy
+1,518
New +$208K ﹤0.01% 1100
2021
Q1
Sell
-2,207
Closed -$247K 1069
2020
Q4
$247K Buy
+2,207
New +$209K ﹤0.01% 647
2020
Q1
Sell
-2,487
Closed -$278K 500
2019
Q4
$278K Buy
+2,487
New +$265K 0.01% 457
2018
Q4
Sell
-2,985
Closed -$236K 328
2018
Q3
$236K Buy
+2,985
New +$231K ﹤0.01% 403
2017
Q3
Sell
-4,227
Closed -$215K 750
2017
Q2
$215K Buy
+4,227
New +$209K ﹤0.01% 658

Other funds holding CNMD

Magnetar Financial's CNMD Position: Q1 2025 in Review

Magnetar Financial sold out of CONMED (CNMD) in Q1 2025, closing a stake of 3,067 shares — an estimated $210K sold.

Magnetar Financial first reported a position in CNMD in Q2 2017 and held it in 11 quarters. The position peaked at $46.5M in Q1 2024. 280 funds tracked by Wall St. Rank hold CNMD as of Q1 2025.

  • Magnetar Financial reported no remaining CONMED position as of Q1 2025 after selling out during the quarter.
  • Magnetar Financial sold 3,067 CONMED shares in Q1 2025, an estimated $210K.
  • Magnetar Financial first reported a position in CONMED in Q2 2017 and held it in 11 quarters.
  • Magnetar Financial's CONMED position peaked at $46.5M in Q1 2024.
  • 280 funds tracked by Wall St. Rank held CONMED as of Q1 2025.

Based on Magnetar Financial's 13F filing for Q1 2025, filed 15 May 2025.